| ²é¿´: 1438 | »Ø¸´: 7 | |||||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||||
mary0312332Òø³æ (СÓÐÃûÆø)
|
[½»Á÷]
[ÇóÖú]ÐéÄâɸѡ
|
||||
|
ÔÚ×öÐéÄâɸѡǰ,Ïë¶ÔС·Ö×Ó¿â×öÒ»¸ö³õ²½µÄɸѡ,ÏëÇë½Ì¸ßÊÖ,Ò»°ãÓ¦ÔõôÉèÖòÎÊý?Èç·Ö×ÓÖÐÔ×ÓÊý, ¼üÊý, ·Ö×ÓÁ¿¾ÍÉè500ÒÔÏ»¹ÊÇÓ¦¸ÃÉÔ´óÓÚ500Ò»µã?ÊèˮλµãÓÖÓ¦¸ÃÔÚʲô·¶Î§? ÒòΪÍêÈ«ÊÇÐÂÊÖ,¶ÔÓÚÕâЩ²ÎÊýʵÔÚÃþ²»×ÅÍ·ÄÔ, Ò²²»ÖªÓ¦¸Ã´ÓÄÄÀï²éÔÄ. Çë¶à¶àÖ¸½Ì ¸Ð¼¤²»¾¡! [search]ÐéÄâɸѡ[/search] [ Last edited by mary0312332 on 2009-4-8 at 16:18 ] |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¼ÆËã¸÷ÖÖÂí¿Ë | ·Ö×Ó¶Ô½Ó |
» ²ÂÄãϲ»¶
0702Ò»Ö¾Ô¸¼ª´óBÇøÇóµ÷¼Á ±¾¿ÆÆÚ¼ä·¢±íһƪSci
ÒѾÓÐ2È˻ظ´
070200Çóµ÷¼Á£¬Ò»Ö¾Ô¸Ä³211£¬288·Ö
ÒѾÓÐ18È˻ظ´
ÎïÀíѧIÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ164È˻ظ´
·¨¹ú²©Ê¿ºóְλ
ÒѾÓÐ0È˻ظ´
ÖØÇì½»´ó26Äê˶ʿÉúÕÐÉúÄâµ÷¼Á֪ͨÒѳö£¡»¶Ó¼ÓÈë»úÆ÷ÊÓ¾õÓë3D¹âѧ³ÉÏñ¿ÎÌâ×é¡£
ÒѾÓÐ0È˻ظ´
**
ÒѾÓÐ1È˻ظ´
0702Ò»Ö¾Ô¸¼ª´óBÇøÇóµ÷¼Á ±¾¿ÆÆÚ¼ä·¢±íһƪSci
ÒѾÓÐ0È˻ظ´
»ùµ×STO,±¡Ä¤SRO£¬XRDÀïÃæµÄÕñµ´£¬ÊÇlaueÕðµ´»¹ÊÇkiessigÕñµ´? ÔõôÅжϣ¿
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
wwbkevin
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 14430.1
- É¢½ð: 15
- ºì»¨: 4
- Ìû×Ó: 376
- ÔÚÏß: 220.1Сʱ
- ³æºÅ: 260064
- ×¢²á: 2006-06-17
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡ï ¡ï
lei0736(½ð±Ò+2,VIP+0):лл
lei0736(½ð±Ò+2,VIP+0):лл
|
Ò»°ã×ñ´ÓLipinski¶¨ÐÔ¹æÔò Lipinski's Rule of Five states that, in general, an orally active drug has: Not more than 5 hydrogen bond donors (OH and NH groups) Not more than 10 hydrogen bond acceptors (notably N and O) A molecular weight under 500 g/mol A partition coefficient log P less than 5 |

2Â¥2008-03-28 22:19:51
yalefield
½ð³æ (ÎÄ̳¾«Ó¢)
ÀϺºÒ»Ã¶
- ¼ÆËãÇ¿Ìû: 2
- Ó¦Öú: 129 (¸ßÖÐÉú)
- ¹ó±ö: 0.17
- ½ð±Ò: 21238.9
- É¢½ð: 3440
- ºì»¨: 66
- Ìû×Ó: 12101
- ÔÚÏß: 759.1Сʱ
- ³æºÅ: 96063
- ×¢²á: 2005-10-07
- רҵ: ¸ßµÈ½ÌÓýѧ
- ¹ÜϽ: ¼ÆËãÄ£Äâ
¡ï ¡ï
lei0736(½ð±Ò+2,VIP+0):лл¾«±Ù¼û½â
lei0736(½ð±Ò+2,VIP+0):лл¾«±Ù¼û½â
|
LipinskiµÄ"5"ÔÔò£¬ÊÇÓëÊý×Ö5Ïà¹ØµÄÔÔò£¬¶ø²»ÊÇ5ÌõÔÔò¡£ ÆäʵÕâÊÇһЩ·Ç³£´ÖÂÔµÄ×ܽᡣ |
3Â¥2008-03-29 02:01:47
ky96998
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 1448
- ºì»¨: 5
- Ìû×Ó: 244
- ÔÚÏß: 33.9Сʱ
- ³æºÅ: 428567
- ×¢²á: 2007-08-04
- ÐÔ±ð: GG
- רҵ: ¼ÆËã»ú¸¨ÖúÒ©ÎïÉè¼Æ
¡ï ¡ï ¡ï ¡ï
lei0736(½ð±Ò+3,VIP+0):лл
mary0312332(½ð±Ò+1,VIP+0):3Q 3-2 16:07
lei0736(½ð±Ò+3,VIP+0):лл
mary0312332(½ð±Ò+1,VIP+0):3Q 3-2 16:07
|
ΪÁ˼õÇá¼ÆËã»úÐéÄâɸѡµÄ¸ºµ££¬ÐéÄâɸѡǰ¶Ô·Ö×Ó¿â½øÐÐɸѡÊÇ¿ÉÐжøÇÒ±ØÒªµÄ¡£ Ò»°ã×ö£º 1¡£ÀàÒ©ÐÔɸѡ£¬ÀàÒ©ÐÔɸѡ¿ÉÒÔÓÃÎ广ÔòÀ´ºâÁ¿£¬Î广ÔòÎҾͲ»¶à˵£¬¿´¿´ÎÄÏ×°É¡£µ«ÊÇÎ广ÔòÒ²ÊÇ¡°¼ûÈʼûÖÇ¡±µÄ£¬²¢²»ÊǶԲ»Í¬µÄ°Ðµã¶¼ÓÃÏàͬµÄÎ广Ôò¡£ 2¡£×öÁËÀàÒ©ÐÔɸѡºó¿ÉÒÔ½øÐлùÓÚҩЧÍŵÄɸѡ¡£Õâ¾ÍÐèÒªÊ×ÏȽ¨Á¢°ÐµãÒÖÖÆÒÖÖÆ¼ÁµÄҩЧÍÅÄ£ÐÍ£¬ÔÙ»ùÓÚUNITYµÈÈí¼þ»ùÓÚҩЧÍÅÄ£ÐͽøÐÐɸѡ¡£ 3¡£½«»ùÓÚҩЧÍÅɸѡ³öµÄ»¯ºÏÎï½øÐзÖ×Ó¶Ô½Ó£¬ÕâÒ»²½Ê×ÏÈ¿ÉÒÔÓÃDOCK£¬¸öÈ˾õµÃsurflexx»¹ÊDz»´í£¬Ëٶȿ졣½«¶Ô½Ó´ò·Ö¸ßµÄ»¯ºÏÎï¿ÉÒÔÔÙ½øÒ»²½ÀûÓÃAUTODOC»òÕßGOLD½øÐо«Ï¸¶Ô½Ó£¬ÌôÑ¡´ò·Ö¸ßµÄ½øÐкϳɲ¢×öÒ©ÀíѧʵÑé¡£ ÕâÑùɸ³öµÄ»¯ºÏÎïÔÚÒ©¶¯¡¢Ò©´ú¡¢¶¾ÐÔ¡¢Ò©ÀíµÈ·½Ãæ¶¼¸ü¿ÉÄÜÂú×ãÒªÇó¡£ÏêϸµÄ·½·¨Òª¿´ÎÄÏ׺Í×Ô¼ºÑ§Ï°ÁË¡£ |
4Â¥2008-03-29 03:14:21
rantingjing
ͳæ (СÓÐÃûÆø)
Ö§³Ö
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
5Â¥2008-03-31 09:54:22
rantingjing
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 44.5
- Ìû×Ó: 53
- ÔÚÏß: 85.7Сʱ
- ³æºÅ: 517512
- ×¢²á: 2008-03-04
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢

6Â¥2008-03-31 09:55:04
7Â¥2008-03-31 20:52:21
wjmed
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2795.1
- ºì»¨: 8
- Ìû×Ó: 812
- ÔÚÏß: 50.4Сʱ
- ³æºÅ: 96805
- ×¢²á: 2005-11-07
- ÐÔ±ð: GG
- רҵ: »¯Ñ§ÉúÎïѧÓëÉúÎïÓлú»¯Ñ§
¡ï ¡ï ¡ï
zzgyb(½ð±Ò+3,VIP+0):ллÄãµÄ²ÎÓ룬»¶Ó¼ÌÐø¹Ø×¢¼ÆËãÄ£Äâ°æ£¡
zzgyb(½ð±Ò+3,VIP+0):ллÄãµÄ²ÎÓ룬»¶Ó¼ÌÐø¹Ø×¢¼ÆËãÄ£Äâ°æ£¡
|
½¨ÒéÄãÏÈ×÷¸öҩЧÍÅ£¬Èí¼þºÜ¶à£¬±ÈÈç ´ÓÊÜÌå³ö·¢£¬Óб±´óÀ´Â³»ª½ÌÊÚ¿ÎÌâ×鿪·¢µÄpocket ´ÓÊÜÌå-ÅäÌåÏ໥×÷Óóö·¢£¬ÓÐligandscout£¬¿ÉÒÔÃâ·ÑʹÓÃ1¸öÔ£¬×ã¹»ÄãÍê³ÉҩЧÍÅÁË È»ºóÏȽøÐÐҩЧÍÅɸѡ£¬Èí¼þÒ²ºÜ¶à£¬Ãâ·ÑµÄÓÐ3dfs£¬ÕâÊÇÖܼҾԽÌÊÚ¿ÎÌâ×鿪·¢µÄ³ÌÐò£¬×îа汾2.0¡£ 3dfsɸѡÍê±ÏµÄ½á¹¹±£´æÎªmol¸ñʽ£¬Äã¿ÉÒÔÖ±½ÓÓÃÕâЩ½á¹ûÈ¥½øÐÐÐéÄâɸѡ¡£ ÎÒÈÏΪ£¬Èç¹ûÖ±½ÓʹÓ÷Ö×Ó¶Ô½ÓÈí¼þÈ¥ÐéÄâɸѡ£¬Èç¹ûΪÁ˿죬¾«¶È²»¿ÉÄܺܺá£ËùÒÔ£¬ÏÈÓÃҩЧÍÅ¿ìËٵĹýһϣ¬ºÜºÃµÄ·½·¨¡£ ¶ÔÓÚ·Ö×Ó¶Ô½Ó£¬ÎÒµ¹ÊǶԸÕÐԶԽӱȽϸÐÐËȤ¡£Ê×ÏÈÊǹ¹ÏóËÑË÷£¬È»ºó½øÐиÕÐÔɸѡ¡£¹¹ÏóËÑË÷Èí¼þÓÐomega£¨openeye)ºÍxedex£¬omega²»ÖªµÀ»¹ÊÇ·ñ¶ÔѧÊõÓû§Ãâ·Ñ£¬µ«ÊÇxedex¿ÉÒÔʹÓÃ1¸öÔµÄÃâ·ÑÊÔÓÃÆÚ¡£ÁíÍ⣬vconfÈí¼þ¶ÔѧÊõÓû§ÊÇÃâ·ÑµÄ£¬¿ÉÒÔÊÔÊÔ¡£ ¸ÕÐÔ¶Ô½ÓµÄÈí¼þ¾ÍºÜ¶àÁË£¬fred£¨openeye£©ÊǺܲ»´íµÄÒ»¸ö£¬¿ÉÒÔÌí¼ÓҩЧÍÅÏÞÖÆ£¬ºÍomegaÊÇͬһ¸ö¹«Ë¾µÄ¡£ÁíÍ⣬¾ÍÊÇdock£¬ºÇºÇ£¬¸öÈËÈÏΪ£¬°Ñ¹¹ÏóËÑË÷ºÍ¶Ô½ÓÒÔ¼°ÆÀ·Ö·Ö¿ª£¬ÄÜÌá¸ß»úÆ÷µÄÀûÓÃÂÊ¡£¶øÇÒ£¬¹¹ÏóËÑË÷Íê±Ï£¬ÒÔºóÆäËû°ÐµãÒ²¿ÉÒÔÖ±½ÓʹÓÃÕâЩ¹¹Ï󼯡£²»¹ý£¬ºÃµÄ¹¹ÏóËÑË÷Èí¼þºÜ¹Ø¼ü¡£catalyst¿Ú±®²»´í£¬¿ÉϧÊÇÉÌÒµµÄ¡£ºÇºÇ ÁíÍ⣬¹ØÓÚÀàÒ©ÐÔ£¨drug-like£©µ¹²»ÊǺÜÖØÒª£¬ÏÖÔÚzincÊý¾Ý¿âÖÐרÃÅÓÐÀàÒ©ÐÔµÄÊý¾Ý¿â£¬¿ÉÒÔÖ±½ÓÏÂÔØ£¬ËùÒÔ£¬ÀàÒ©ÐÔɸѡÍêÈ«¿ÉÒÔÊ¡ÂÔ¡£µ±È»£¬²»Ê¹ÓÃzincÊý¾Ý¿â£¬¸ÃÁíµ±±ðÂÛ¡£ [ Last edited by wjmed on 2008-4-1 at 08:13 ] |

8Â¥2008-04-01 08:10:15














»Ø¸´´ËÂ¥

